Research that Advances Precision Medicine for Brain Disorders
Our Neurogenomics researchers us basic and translational studies to discover genomic mechanisms and advance precision medicine for brain disorders. The research team conducts genome-sequencing and genome-wide association studies to identify risk variants for disorders including sychiatric disorders, substance use disorders, brain injury, and neurodegeneration.
They use also use single-cell multiomic technologies to characterize cell type diversity and disease-associated transcriptomic and epigenomic changes in many regions of the human and mammalian brain--and characterize the genes and variants that emerge from these studies using human stem cells and animal models